Industry News
Antibodies implicated in severe dengue virus-induced disease
The La Jolla Institute for Allergy & Immunology has validated the longheld theory that antibodies actually contribute to severe dengue virus-induced disease.
[ + ]Qiagen and Celera establish distribution agreement for respiratory pathogen panel
Qiagen is to distribute a Celera molecular multiplex assay for detection of respiratory pathogens.
[ + ]Molecular causes of genetic diseases
A new study using bioinformatics, led by scientists at the Buck Institute for Age Research, reports the ability to predict the molecular cause of many inherited genetic diseases. These predictions involve tens of thousands of genetic disease-causing mutations and have led to the creation of a web-based tool available to academic researchers who study disease.
[ + ]Lorne special: Piecing together the breast cancer puzzle
Just when things seemed to be going around in circles, some quite unexpected data from WEHI has opened up an exciting new avenue in breast cancer research. [ + ]
Lorne special: Mortality, metastasis and miRNAs
Greg Goodall’s Adelaide research group has explored found tantalising links between the miR-200 gene family and metastasis in a wide range of cancers. [ + ]
Chemistry and computers combine for forensic identification
Researchers at The University of Western Australia and the WA Police Service are part of an international team awarded an Australia Research Council Discovery grant of more than $400,000 to revolutionise the identification of skeletal remains by updating and combining new computer and chemical methods.
[ + ]QRxPharma initiates second pivotal phase III study of MoxDuo IR Dual-Opioid for NDA submission
Evaluate analgesic efficacy and safety of MoxDuo IR in patients with moderate to severe post-operative pain following total knee replacement surgery. [ + ]
Living Cell Technologies swaps license for portion of US company
Living Cell Technologies received 10 per cent of US startup, CytoSolv, in exchange for technology licence. [ + ]
Lorne special: Dynamic dynamin and synaptic transmission
Dynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy. [ + ]
BioProspect a step closer to commercialising natural anti-termite repellent
APVMA registers Erimophilone Oil as an active ingredient, end-user product could be available within two years. [ + ]
Australian biotech market watch 05/02/10
CSL, ResMed, Living Cell Technology, Mesoblast, Prima BioMed, Sirtex Medical, CathRx [ + ]
Another malaria breakthrough offers potential drug target
Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood. [ + ]
Lorne special: Cell polarity and the T-cell
A collaborative venture between Sarah Russell at Peter Mac and microscopists at Swinbourne University of Technology is yielding insights into the behaviour of T cells. [ + ]
Australian biotech market watch 02/02/10
CathRX, Mesoblast, ChemGenex, Living Cell Technologies, QRxPharma, CSL, ResMed, Cochlear [ + ]
Promising anti-malaria target found
Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target. [ + ]